Alzheimer's Tau Platform: Master Protocol
Abroad (travel likely)RecruitingPHASE2
Conditions
Preclinical Alzheimer's Disease · Alzheimer Disease · Prodromal Alzheimer's Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California, San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Peter Ljubenkov, MD)
Study leads
Adam Boxer, MD, PhD
Principal Investigator
University of California, San Francisco (UCSF), Memory and Aging Center
Keith Johnson, MD
Principal Investigator
Massachusetts General Hospital (MGH), Harvard Medical School